Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Oguzhan Zengi"'
Publikováno v:
Journal of Medical Biochemistry. Oct-Dec2023, Vol. 42 Issue 4, p600-606. 7p.
Autor:
Hikmet Can Çubukçu, Alper Gümüş, Cihan Coskun, Derya Sonmez, Ipek Cinaroglu, Bagnu Orhan, Oguzhan Zengi, Humeyra Ozturk Emre, Murat Keles
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 59:837-843
Objectives The utilization of reliable quality indicators (QIs) proven to be suitable for monitoring and improvement tools is one of the best choices to minimize of the risk of errors in all laboratory processes called as total testing process (TTP).
Autor:
Oguzhan Zengi, Kucuk, Suat H.
Publikováno v:
Clinical Laboratory; 2021, Vol. 67 Issue 10, p2316-2322, 7p
Autor:
Evrim Ebru Kovalak, Tolga Karacan, Oğuzhan Zengi, Özlem Karabay Akgül, Şefik Eser Özyürek, Hakan Güraslan
Publikováno v:
Gynecological Endocrinology, Vol 39, Iss 1 (2023)
Objective To investigate the efficacy of new endometriosis biomarkers in diagnosis and treatment.Methods Thirty women with Stage III-IV endometriosis who were given an indication for surgery and 49 control patients were compared. Preoperative and pos
Externí odkaz:
https://doaj.org/article/57388ff30a9749b195f7eb3a6e2c2771
Publikováno v:
International urology and nephrology. 50(2)
To investigate whether atorvastatin has favorable effects on urinary metabolic risk factors associated with urolithiasis. Sixteen male Sprague–Dawley rats were randomly divided into two groups, and baseline spot and 24-h urine samples were collecte
Autor:
Omer Onur, Cakir, Mehmet Gokhan, Culha, Serdar, Arisan, Elif Damla, Arisan, Murat, Altin, Sam, Ward, Oguzhan, Zengi, Erbil, Ergenekon
Publikováno v:
Urology journal. 14(4)
To compare the serum antioxidant enzyme levels between patients with urinary stone disease and healthy volunteers to determine the effect of cellular oxidative stress on urinary calcium oxalate stones formation.Materialsamp; Methods: A total of 51 pa
Autor:
Ahmet Omma, Ayse Batirel, Mehtap Aydin, Fatma Yilmaz Karadag, Abdulsamet Erden, Orhan Kucuksahin, Berkan Armagan, Serdar Can Güven, Ozlem Karakas, Selim Gokdemir, Lutfiye Nilsun Altunal, Aslihan Ayse Buber, Emin Gemcioglu, Oguzhan Zengin, Osman Inan, Enes Seyda Sahiner, Gulay Korukluoglu, Zafer Sezer, Aykut Ozdarendeli, Ates Kara, Ihsan Ates
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 6 (2022)
Protective neutralizing antibody titers reduce in time after COVID-19 vaccinations, as in individuals who have had COVID-19. This study aimed to evaluate the safety and immunogenicity of CoronaVac and TURKOVAC vaccines used as a booster dose after Co
Externí odkaz:
https://doaj.org/article/8c21a7499126460eb2a45f3715e4845c
Autor:
Yaser Snoubar, Oǧuzhan Zengin
Publikováno v:
Frontiers in Psychology, Vol 13 (2022)
COVID-19 has been studied extensively for its direct effects on healthcare workers. Despite this, very little is known about the effect of COVID-19 fear on future orientation. Studying medical social workers’ fear of being infected with COVID-19 an
Externí odkaz:
https://doaj.org/article/27c6bbdbdfca4731afb2a2f8bc1440cc
Autor:
Ihsan Ates, Ayse Batirel, Mehtap Aydin, Fatma Yilmaz Karadag, Abdulsamet Erden, Orhan Kucuksahin, Berkan Armagan, Serdar Can Guven, Ozlem Karakas, Selim Gokdemir, Lutfiye Nilsun Altunal, Aslihan Ayse Buber, Emin Gemcioglu, Oguzhan Zengin, Osman Inan, Enes Seyda Sahiner, Gulay Korukluoglu, Zafer Sezer, Aykut Ozdarendeli, Ahmet Omma, Ates Kara
Publikováno v:
Vaccines, Vol 11, Iss 7, p 1234 (2023)
The immunogenicity of vaccines decreases over time, causing a need for booster doses. This study aimed to present the long-term (Day 84) immunogenicity results of the double-blind, randomized, controlled, phase II Hybrid COV-RAPEL TR Study (NCT049799
Externí odkaz:
https://doaj.org/article/de676a2951d24c999afea7276d33f31e
Autor:
Özlem Bostan Gayret, Mehmet Taşdemir, Meltem Erol, Hikmet Tekin Nacaroğlu, Oğuzhan Zengi, Özgül Yiğit
Publikováno v:
Renal Failure, Vol 40, Iss 1, Pp 416-422 (2018)
Aim: The aim of this study was to examine the serum and urine levels of kidney injury molecule-1 (KIM-1), neutrophil gelatinase-associated lipocalin (NGAL), osteopontin (OPN), matrix metalloproteinase-9 (MMP-9), and serum Cystatin-C to determine the
Externí odkaz:
https://doaj.org/article/96573c1b67ba4a6aaa4e293ffcec350c